CD274 and colorectal carcinoma: Current research focuses on identifying composite scores to predict response to immunotherapy in CRC, encompassing different variables, such as the expression of PD-L1 and the percentage of extracellular mucin (CPM score) [88], and other immune biomarkers from the TME.